Thyroid Hormone as a Prophylactic Agent Following Radical Treatment of Breast Cancer

. 1965 Mar;19(1):116–121. doi: 10.1038/bjc.1965.12

PMCID: PMC2071432 PMID: 14284372

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

EDELSTYN G. A., LYONS A. R., WELBOURN R. B. Thyroid function in patients with mammary cancer. Lancet. 1958 Mar 29;1(7022):670–671. doi: 10.1016/s0140-6736(58)91088-2. [DOI] [PubMed] [Google Scholar]
GARDNER B., THOMAS A. N., GORDAN G. S. Antitumor efficacy of prednisone and sodium liothyronine in advanced breast cancer. Cancer. 1962 Mar-Apr;15:334–337. doi: 10.1002/1097-0142(196203/04)15:2<334::aid-cncr2820150216>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
REEVE T. S., RUNDLE F. F., HALES I. B., MYHILL J., CROYDON M. Thyroid function in the presence of breast cancer. Lancet. 1961 Mar 25;1(7178):632–633. doi: 10.1016/s0140-6736(61)91653-1. [DOI] [PubMed] [Google Scholar]
WILKINS R. H., MORTON D. L. The influence of thyroid hormone analogues on an isotransplanted spontaneous mammary adenocarcinoma in mice. Cancer. 1963 May;16:558–563. doi: 10.1002/1097-0142(196305)16:5<558::aid-cncr2820160503>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]